The adsorbent column reduced the percentage of LAP+ cells in peripheral blood and upregulated cytotoxic T-lymphocyte (CTL) responses against tumor cells, resulting in improvement in survival of the rats. This evidence concerns the gene TGFB1 and neoplasm.